MDRAAC

The feature of our product antibody- antibiotic conjugate drugs is that two different drugs can be bonded to the antibody to provide a feasible strategy for bacterial resistance. Our product mainly targets patients with recurrent infection caused by Klebsiella pneumoniae, and combines the antibiotics and antibody-antibiotic conjugated drugs development.

#People #Event #More

MDRAAC

Industry:
Health Care

Address:
Taipei, T'ai-pei, Taiwan

Country:
Taiwan

Status:
Active

Contact:
+886-937833365

Email Addresses:
[email protected]


Founder


not_available_image

Wei-Kuang Chi

Newest Events participated

ces-las-vegas-2022_event_image Participated in CES Las Vegas 2022 on 2022-01-05 as exhibitor

More informations about "MDRAAC" on Search Engine